Germany long-acting bronchodilator market is anticipated to grow at a substantial rate of 4.2% during the forecast period. Germany is one of the key economies of the European region in terms of revenue generation and future opportunity for long-acting bronchodilator market. As per the International Monetary Fund, the population of the country was about 80 million and the share of the geriatric population is about 21%. Factors that augment the growth of the market in the country include a significant prevalence of asthma and COPD and the presence of market players focusing on the development of respiratory drugs and devices. Furthermore, market players are adopting various strategies that are transforming the industry scenario in the country. For instance, Ingelheim-based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The aim of the collaboration is to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD.
To Request a Sample of our Report on Germany Long-Acting Bronchodilator Market: https://www.omrglobal.com/request-sample/germany-long-acting-bronchodilator-market
Germany long-acting bronchodilator market is segmented on the basis of route of administration, application, and end-user. Based on the route of administration, the market is classified into oral, nasal, parenteral, and inhalation. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. The asthma disease application segment dominated the regional market in 2018 and is further estimated to follow the same trend over the forecast period. This is mainly due to the high prevalence of asthma in the country and rising demand for its various treatment solutions. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A full Report of Germany Long-Acting Bronchodilator Market is Available @ https://www.omrglobal.com/industry-reports/germany-long-acting-bronchodilator-market
Germany Long-Acting Bronchodilator Market Segmentation
By Route of Administration
- Oral
- Nasal
- Parenteral
- Inhalation
By Application
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
By End-User
- Homecare
- Hospitals and Clinics
Company Profiles
- Adamis Pharmaceuticals Corp.
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- GlaxoSmithKline PLC
- Novartis AG
- ResMed Corp.
- Pulmatrix Inc.
- Savara, Inc.
- Sunovion Pharmaceuticals
- Teva Pharmaceuticals Industries Ltd.
- Vitalograph Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
